Impact of Obesity on Response to Therapy and Clinical Outcom in Patients With Inflammatory Bowel Disease
Observational · No treatment assigned · Sites not listed yet · Assiut University
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Inflammatory Bowel Disease (IBD). This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- Adults (>18 years) diagnosed with IBD
- Currently receiving standard treatment (including biologics)
There are also 3 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 120 participants are expected to take part.
- Start date: 2026-02 (planned).
- Main results expected around 2027-02 (estimate from the record).
- No study sites are listed yet. Check the official record for contact details.
Main thing being measured
- improvement rate of patients (3 months)
In the researchers’ words
Inflammatory Bowel Disease (IBD), which includes ulcerative colitis (UC) and Crohn's disease (CD), is a group of chronic relapsing inflammatory disorders of the gastrointestinal tract. Its pathogenesis is multifactorial, involving genetic predisposition, environmental triggers, immune dysregulation, and microbial imbalance.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Inflammatory Bowel Disease (IBD) |
| Lead sponsor | Assiut University |
| Enrollment | 120 (estimated) |
| Start date | 2026-02 |
| Primary completion (est.) | 2027-02 |
| First posted | 2026-01-15 |
| Last updated | 2026-01-15 |
| Official title | Impact of Obesity on Response to Therapy and Clinical Outcom in Patients With Inflammatory Bowel Disease |
| ClinicalTrials.gov ID | NCT07343726 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * Adults (>18 years) diagnosed with IBD * Currently receiving standard treatment (including biologics) Exclusion Criteria: * Patients with other causes of colitis (e.g. infectious, ischemic) * Pregnant females * Incomplete clinical or follow-up data
Locations (0)
No sites listed yet. The official record has contact information.
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.